Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis

Herr, I, Wilhelm, D, Bohler, T, Angel, P and Debatin, KM (1997) Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. Embo Journal, 16 20: 6200-6208. doi:10.1093/emboj/16.20.6200


Author Herr, I
Wilhelm, D
Bohler, T
Angel, P
Debatin, KM
Title Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
Journal name Embo Journal   Check publisher's open access policy
ISSN 0261-4189
Publication date 1997-10
Sub-type Article (original research)
DOI 10.1093/emboj/16.20.6200
Volume 16
Issue 20
Start page 6200
End page 6208
Total pages 9
Language eng
Keyword cellular stress
doxorubicin
gamma-irradiation
JNK-SAPKs
Niemann-Pick
Tumor-Necrosis-Factor
Radiation-Induced Apoptosis
Human T-Cells
Sphingomyelinase-Deficient Mice
Daunorubicin-Induced Apoptosis
Niemann-Pick Disease
C-Jun
Poly(adp-Ribose) Polymerase
Receptor/ligand System
Protein-Kinases
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 253 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 259 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 33 Abstract Views  -  Detailed Statistics
Created: Sat, 10 Sep 2011, 09:44:41 EST by System User